Acute antihypertensive therapy in pregnancy-induced hypertension: Is nicardipine the answer?

American Journal of Perinatology

Volumn 26, Issue 7, 2009, Pages 495-499

  Vadhera, Rakesh B ^a   Pacheco, Luis D ^a,b   Hankins, Gary D V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Hypertension; Nicardipine; Preeclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; GLYCERYL TRINITRATE; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; THIOSULFATE;

ADD ON THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN ISCHEMIA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECLAMPSIA; FETUS DISTRESS; FETUS OUTCOME; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART STROKE VOLUME; HOT FLUSH; HUMAN; HYPOTENSION; INDUCED HYPOTENSION; KIDNEY ISCHEMIA; MATERNAL HYPERTENSION; NAUSEA; NEONATAL THROMBOCYTOPENIA; NEWBORN MORBIDITY; NEWBORN MORTALITY; NEWBORN PERIOD; NONHUMAN; OBSTETRICS; PLACENTA CIRCULATION; PLACENTAL TRANSFER; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLEX TACHYCARDIA; REVIEW; SHORT COURSE THERAPY; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE ATONY; UTERUS BLOOD FLOW; UTERUS CONTRACTION; VOMITING;

ACUTE DISEASE; BLOOD PRESSURE DETERMINATION; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; MALE; NICARDIPINE; PERINATAL MORTALITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 67749110408     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1214251     Document Type: Review

References (35)

1. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992;99:547-553
2. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest 2007;131:1949-1962
3. The Fifth Report of the Joint National Committee on Detection. Evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183
4. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-265
5. Lipshitz J, Ahokas RA, Reynolds SL. The effect of hydralazine on placental perfusion in the spontaneously hypertensive rat. Am J Obstet Gynecol 1987;156:356-359 (Pubitemid 17020490)
6. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005;105:246-254 (Pubitemid 40229437)
7. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006;3:CD001449
8. Lunell NO, Lewander R, Nylund L, Sarby B, Thornstrom S. Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. Gynecol Obstet Invest 1983;16:274-282
9. Vink GJ, Moodley J. The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 1982;62:475-477
10. Lindheimer MD, Katz AI. Hypertension in pregnancy. N Engl J Med 1985;313:675-680
11. Davey D, Adommisse J, Garden A. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. In: Riley A, Symonds EM, eds. The Investigation of Labetalol in the Management of Hypertension in Pregnancy: Proceedings of a Symposium at the Royal College of Physicians. Amsterdam: Excerpta Medica; 1982:51-61
12. Shepherd AM, Ludden TM, McNay JL, Lin MS. Hydralazine kinetics after single and repeated oral doses. Clin Pharmacol Ther 1980;28:804-811 (Pubitemid 11213117)
13. Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987;70:328-333 (Pubitemid 17151650)
14. Hall VA, Guest JM. Sodium nitroprusside induced cyanide intoxication and prevention with sodium thiosulphate prophylaxis. Am J Crit Care 1992;1:19-27
15. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancy. Crit Care Med 2005;33:S307-S312
16. Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol 1988;95:1276-1281 (Pubitemid 19032909)
17. Hanretty KP, Whittle MJ, Howie CA, Rubin PC. Effect of nifedipine on Doppler flow velocity waveforms in severe preeclampsia. BMJ 1989;299:1205-1206 (Pubitemid 19281172)
18. Moretti MM, Fairlie FM, Akl S, Khoury AD, Sibai BM. The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term. Am J Obstet Gynecol 1990;163:1844-1848
19. Bennett P, Edwards D. Use of magnesium sulphate in obstetrics. Lancet 1997;350:1491
20. Von Dadelszen P, Magee LA. Antihypertensive medications in management of gestational hypertension-preeclampsia. Clin Obstet Gynecol 2005;48:441-459
21. Wallin JD, Cook ME, Blanski L, et al. Intravenous nicardipine for the treatment of severe hypertension. Am J Med 1988;85:331-338 (Pubitemid 18231354)
22. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancy. Crit CareMed 2005;33:S307-S312
23. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest 2000;118:214-227
24. Aya AG, Mangin R, Hoffet M, Eledjam JJ. Intravenous nicardipine for severe hypertension in preeclampsia-effects of an acute treatment on mother and fetus. Intensive Care Med 1999;25:1277-1281
25. Carbonne B, Jannet D, Touboul C, Khelifati Y, Milliez J. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993;81:908-914
26. Elatrous S, Nouira S, Ouanes L, et al. Short term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med 2002;28:1281-1286 (Pubitemid 35025047)
27. Hanff LM, Vulto AG, Bartels PA, et al. Intravenous use of the calcium channel blocker nicardipine as second line treatment in severe, early onset preeclamptic patients. J Hypertens 2005;23:2319-2326
28. Ducsay CA, Thompson JS, Wu AT, Novy MJ. Effects of calcium entry blocker (Nicardipine) tocolysis in rhesus macaques: fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol 1987;157:1482-1486
29. Parisi VM, Salinas J, Stockmar EJ. Placental vascular responses to nicardipine in the hypertensive ewe. Am J Obstet Gynecol 1989;161:1039-1043 (Pubitemid 19266228)
30. Parisi VM, Salinas J, Stockmar E. Fetal vascular response to maternal nicardipine administration in the hypertensive ewe. Am J Obstet Gynecol 1989;161:1035-1039 (Pubitemid 19266227)
31. Holbrook JH Jr, Voss EM, Gibson RN. Ovine fetal cardiorespiratory response to nicardipine. Am J Obstet Gynecol 1989;161:718-721 (Pubitemid 19252793)
32. Aya AG, Bruelle P, Lefrant JY, Saissi G, Ferrer JM, Eledjham JJ. Accidental nicardipine overdosage without serious maternal or neonatal consequence. Anaesth Intensive Care 1996;24:99-101 (Pubitemid 26068725)
33. Jannet D, Abankwa A, Guyard B, Carbonne B, Marpeau L, Milliez J. Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study. Eur J Obstet Gynecol Reprod Biol 1997;73:11-16 (Pubitemid 27224454)
34. Jannet D, Carbonne B, Sebban E, Milliez J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol 1994;84:354-359 (Pubitemid 24267291)
35. Kobayashi A, Mizobe T, Tojo H, Hashimoto S. Autonomic hyperreflexia during labour. Can J Anaesth 1995;42:1134-1136